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Background: Obesity, characterised by increased fat mass and is currently regarded as a pro-inflammatory state
and often associated with increased risk of cardiovascular diseases (CVD) including Myocardial infarction. There is an
upregulation of inflammatory markers such as interleukin-6, interleukin-6 receptor and acute phase protein CRP in
Acute Myocardial Infarction (AMI) patients but the exact mechanism linking obesity and inflammation is not known.
It is of our interest to investigate if serum leptin (ob gene product) is associated with AMI and correlated with
inflammatory proteins namely Interleukin-6 (IL-6) and high sensitivity - C reactive protein (hs-CRP).
Results: Serum leptin levels were significantly higher in AMI patients when compared to Non-CVD controls. IL-6
and hs-CRP were also elevated in the AMI group and leptin correlated positively with IL-6 and hs-CRP. Incidentally
this is the first report from Chennai based population, India.
Conclusions: The strong correlation between serum levels of leptin and IL-6 implicates an involvement of leptin in
the upregulation of inflammatory cytokines during AMI. We hypothesise that the increase in values of IL-6, hs-CRP
and their correlation to leptin in AMI patients could be due to participation of leptin in the signaling cascade after
myocardial ischemia.
Keywords: Leptin, IL-6, CRP, Obesity, Cardiovascular disease, Acute myocardial infarctionBackground
Myocardial Infarction (MI) is a major cause of death glo-
bally and worldwide studies have indicated that nine
modifiable risk factors including obesity, hypercholester-
olemia, hypertension is up to 90% [1] in patients pre-
senting with MI. There are substantial evidences
implicating that obesity is a strong risk factor for the de-
velopment of MI. In addition, even a moderate increase
in body mass index (BMI) is associated with an
increased risk of heart failure [2]. Patients with Chronic
Heart Failure are characterized by metabolic abnormal-
ities the process involving several endocrines including
the adipocytic hormone leptin [3].
Leptin, the ob gene product was discovered because of
its very specific biological action: the ability to regulate
body weight and appetite [4]. Leptin is also known to play* Correspondence: r_malathi@hotmail.com
1Department of Genetics, Dr.ALMPGIBMS, University of Madras, Chennai
-600113, India
Full list of author information is available at the end of the article
© 2012 Karthick et al.; licensee BioMed Centra
Commons Attribution License (http://creativec
reproduction in any medium, provided the orimportant role in reproduction, hematopoiesis, immunity
and angiogenesis [4,5]. Interestingly, leptin has a structure
similar to that of the family of helical cytokines namely
interleukins. Thus, leptin shares an extreme functional
pleiotropy with other cytokines and is involved in quite di-
verse physiological functions. Leptin exerts its biological
influence by binding to its receptor (OB-R), which belongs
to the class I cytokine receptor superfamily [4]. The func-
tional leptin receptors are distributed widely including the
hypothalamus, immune cells, myocardium etc.,. In
humans, obese individuals possess high values of circulat-
ing leptin, which may fail to signal for energy expenditure,
suggesting that most human obesity represents a form of
leptin resistance.
Reports have suggested that obesity is characterized by
inflammation – paralleling the condition with other dis-
eases. It is fairly well established that leptin could be a
major link between obesity and inflammation in CVD. A
number of inflammation-related proteins are released by
adipocytes and these include leptin, cytokines, chemokinesl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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clude endothelial cell activation with subsequent stimula-
tion of pro-inflammatory cytokines [6-8]. Studies have
also suggested that leptin is capable of activating immune
cells or might initiate a direct action on the vascular wall,
thereby leading to initiation and progression of athero-
sclerosis [9]. In MI patients, who are thrombolysed, severe
endothelial dysfunction in the infarct-related arteries is
observed [10] with increase in inflammatory cytokines
such as IL-6 and also its signaling product CRP. Circulat-
ing IL-6 levels constitute a significant pro-atherogenic
cytokine and serum IL-6 concentration was an independ-
ent predictor of cardiovascular mortality [11]. It is how-
ever, not clear as to what extent adipose tissue,
particularly leptin contributes quantitatively to the ele-
vated circulating levels of acute phase proteins and cyto-
kines in obesity and whether there is a generalized or local
state of inflammation [12].
Previous studies have reported that severity and ex-
pression of various factors in CVD depend on different
population [13,14]. We therefore focused on Chennai
based population with an attempt to understand if
serum leptin concentration is associated with myocardial
infarction, with particular emphasis on the relationship
between serum leptin and inflammatory markers such as
IL-6 and CRP in AMI condition. The aim of the present
study is 3 fold: ie; 1. to determine circulating leptin, IL-
6, hs-CRP levels in both AMI and control subjects and
correlate it to BMI, 2. to investigate the relationship be-
tween leptin and IL-6, leptin and hs-CRP and 3. to ana-
lyse if leptin associated with IL-6 and hs-CRP is an
independent predictor of CVD in patients diagnosed for
AMI.Results
Serum levels of leptin, IL-6 and CRP were evaluated for
93 Acute Myocardial Infarction (AMI) patients and 102
control subjects (Table 1). Their age, BMI, systolic andTable 1 Values of BMI, serum leptin, hs-CRP and IL-6 IN AMI a
Class N BMI (kg/m2)
Normal weight Control 21 21.5629±1.32228
AMI 51 20.0673±1.13373
P Value *P<0.030
Over weight Control 45 24.7096±1.24606
AMI 29 26.0700±1.38817
P Value *P<0.033
Obese Control 36 31.6586±3.47939
AMI 13 29.4408±1.4798
P Value 2 **P<0.005
The values are mean±standard deviation. *P=0.05, **P=0.01, is given with the statisdiastolic blood pressure, pulse rate were recorded. Both
Systolic and Diastolic blood pressure and the pulse rate
were found to be significantly higher in AMI patients
(Table 2).
Serum concentration of leptin was elevated in AMI
Patients compared to controls and this difference was
statistically significant. Table 1 shows the increased
values of IL-6, hs-CRP in AMI patients and a strong
positive correlation was observed between serum levels
of leptin and that of IL-6 (r = 0.862, p = 0.001). Correl-
ation was also observed between leptin and hs-CRP
(r = 0.318, p = 0.002) in these patients but significant cor-
relation was not observed between leptin and hs-CRP
(r = 0.209, p = 0.035), leptin and IL-6 (r = 0.259, p = 0.009)
in control subjects (Table 3).
Correlation between serum parameters such as leptin,
IL-6 and hs-CRP was further assessed by linear regres-
sion analysis. A positive correlation was found between
serum leptin concentration and IL-6 in AMI (R2 = 0.
742) (Figure 1A.), while such a relation was not observed
in the control group (R2 = 0.059) (Figure 2A). A similar
analysis has also indicted that serum leptin concentra-
tion was related to hs-CRP in AMI (R2 = 0.154)
(Figure 1B) but not related in control group (R2 = 0.002)
(Figure 2B).Discussion
The objective of our study was to compare values of
serum leptin, hs-CRP, IL-6 levels in AMI patients with
that of healthy control subjects. Patients with AMI had
increased serum levels of leptin compared to control
subjects. There was a significant correlation between
leptin and BMI in both AMI and control subjects in the
three categories including normal, overweight and obese.
It is understood that leptin correlates with BMI [15,16],
although serum leptin concentration in each AMI group
was very high and almost double the values obtained for
respective control groups. Interestingly, we found thatnd control subjects










tical significance between AMI and Control subjects.
Table 2 Values of systolic and diastolic blood pressure,
pulse rate in AMI and control subjects.
Control subjects AMI subjects P Value
Systolic Blood Pressure 122.21±15.263 138.17±22.027 **P<0.001
Diastolic Blood Pressure 84.26±11.244 94.09±13.612 **P<0.001
Pulse Rate 74.40±7.805 85.19±7.497 **P<0.001
The values are mean±standard deviation. *P=0.05, **P=0.01, is given with the
statistical significance between AMI and Control subjects.
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26.70 ± 10.426 ng/ml) is similar to that of leptin concen-
tration of control obese group (mean 27.06 ± 12.430 ng/
ml). This explains that leptin is not only a BMI
dependent parameter but in pathological conditions
could be determined by inflammation and metabolic
defects as observed in AMI patients. Reports have sug-
gested that in humans, serum leptin concentrations re-
flect the amount of adipose tissue in the body [17]. In
obese subjects the observed increase in leptin values is
attributed to leptin resistance and hyperleptinemia is
associated with elevated blood pressure. In the present
study the systolic and diastolic blood pressure and the
recorded pulse rate was high in AMI patients.
A strong positive correlation was demonstrated be-
tween serum levels of leptin and IL-6 in patients with
AMI and control subjects, Serum leptin was found to be
correlated with hs-CRP values in both groups. Linear re-
gression analysis was performed further to find the pre-
dictor of leptin, markedly higher leptin concentrations
correlated with mostly IL-6 (R2 = 0.742) than with hs-
CRP (R2 = 0.154). It appears therefore that leptin concen-
tration is translated into changes in IL-6 concentration
possible at the level of IL-6 gene expression. Leptin is
not usually thought of as an inflammatory cytokine,
hyperleptinemia has been shown to be induced by in-
flammatory signals [18]. The strong correlation of serum
levels of leptin with IL-6 implicates an involvement of
leptin in releasing the cytokines during MI. Therefore
we suggest that IL-6 secretion is enhanced by leptin in
addition to the other factors. Several other studies also
suggest that leptin can modulate immune cells by stimu-
lating the production of pro inflammatory cytokines [19-
21]. Although we did not evaluate the expression ofTable 3 Spearman’s correlation coefficient analysis of
leptin with BMI, hs-CRP and IL-6
Variables Control subjects AMI subjects
Leptin Leptin
R p R p
BMI 0.337** 0.001 0.370** 0.001
hs-CRP 0.209* 0.035 0.318** 0.002
IL-6 0.259** 0.009 0.862** 0.001
**- Correlation is significant at the 0.01 level.
*- Correlation is significant at the 0.05 levelleptin receptor in our samples, we can speculate that the
observed increase in the levels of Leptin, IL-6 and hs-
CRP in AMI patients could be due to the presence of an
increased number of activated vascular endothelial cells,
adipocytes, immune cells, associated with an up regula-
tion of leptin receptor expression.
The findings of the present study are consistent with
and compliment the results of previous studies on leptin
in chronic heart diseases such as ACS [9] and CHF
[22,23]. We have demonstrated for the first time, a rela-
tionship between increased levels of leptin, hs-CRP and
IL-6 the progressive impairment in Non-Thrombolysed
condition of AMI in Chennai based population. Thus,
adipocyte-derived hormone leptin might be involved in
metabolic abnormalities leading to AMI or leptin might
be cardioprotective in ischemia/reperfusion injury [24].
Inflammation and angiogenesis play an important role in
healing of injured tissue. In this approach, the activation
of the immune system by leptin, together with its angio-
genic effect, suggests that leptin may be involved in in-
flammatory reaction in the infarcted tissue and induce
tissue repair.Conclusion
High values of leptin as obtained from our study may re-
flect an ubiquitous susceptibility of peripheral tissues to
the action of leptin. The upregulation of IL-6 and the in-
crease in its signaling product hs-CRP suggests the pos-
sible involvement of leptin in the signaling cascade
through activation of leptin receptor after myocardial is-
chemia. Our results demonstrate that serum leptin may
be a useful marker of inflammation and it may be help-
ful in assessing the risk of obesity associated CVD. Fu-
ture studies should focus on the expression of leptin, its
receptor in myocardium and their role in underlying
pathogenesis of MI.Materials and methods
Population study
The study was carried out on 195 subjects (93 AMI sub-
jects and 102 voluntary BMI, and age matched healthy
people as controls) after obtaining written consent. Per-
ipheral venous blood was collected from patients imme-
diately after admission (Non thrombolysed) at ICCU,
Department of Cardiology, Stanley Medical Hospital,
Chennai. Clinical diagnosis of AMI was made from ECG
with ST-segment Elevation (STEMI) and non-ST-
segment elevation (Non-STEMI) with typical chest pain
persisting for at least 30 min, ST segment
elevation > 0.2 mV in at least 2 contiguous leads. From
the blood samples collected, serum was isolated after
centrifugation at 3,500 rpm and stored at −20°C for sub-














R Sq Linear = 0.154











R Sq Linear = 0.742
Leptin Vs IL-6
A
Figure 1 Correlation between serum levels of leptin (ng/ml), IL-6 (pg/ml) and hs-CRP (mg/L) in patients with AMI (Linear regression
analysis). A. Correlation between serum leptin (ng/ml) and IL-6 (pg/ml) in patients with acute myocardial infarction. Significant positive
correlation is found (R2 = 0. 742). B. Correlation between serum leptin (ng/ml) and hs-CRP (mg/L) in patients with acute myocardial infarction.
Positive correlation is found (R2 = 0.059).
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CVD) at University of Madras Staff quarters, Palavakam,
Chennai. Controls comprised of healthy subjects who had
no history of chest pain or symptoms suggestive of CVD.
Clinical parameters including blood pressure and pulse
rate was measured for all the subjects by trained medical
practitioners and anthropometric parameter - BMI was
calculated as [weight (kg)/height (m2)].ELISA assays
Serum leptin was measured using ‘two-step’ sandwich ELISA
kit [Diagnostics Biochem Canada Inc. (DBC)]. IL-6 was mea-
sured using ‘two-step’ sandwich ELISA kit [Ani Biotech OY,
Orgenium Laboratories Business Unit, Finland]. hs-CRP was
measured using turbidimetric method [Spinreact, S.AU. Ctra.
Santa Coloma]. Laboratory procedures were performed














R Sq Linear = 0.002













R Sq Linear = 0.059
Leptin Vs IL-6 
A
B
Figure 2 Correlation between serum levels of leptin (ng/ml), IL-6 (pg/ml) and hs-CRP (mg/L) in control subjects (Linear regression
analysis). A. Correlation between serum leptin (ng/ml) and IL-6 (pg/ml) in control subjects. No significant correlation is found (R2 = 0.154). B.
Correlation between serum leptin (ng/ml) and hs-CRP (mg/L) in control subjects. No significant correlation is found (R2 = 0.002).
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Statistical analysis was performed using SPSS software (ver-
sion 15.0). For better comparison mean±S.D. is shown.
Correlation between variables was examined by estimating
Spearman’s correlation coefficient (rs) (data not normally
distributed). A simple linear regression analysis was per-
formed to identify the predictors of serum leptin. The
adjusted coefficient of determination (adjusted R2) was used
to measure the goodness-of-fit of the final model.Abbreviations
CVD: Cardio Vascular Disease; AMI: Acute Myocardial Infarction; hs-CRP: High
sensitivity-C Reactive Protein, IL-6, Interleukin 6; BMI: Body Mass Index;
BP: Blood pressure.
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